期刊文献+

肾肿瘤磁共振多 b 值扩散加权成像的初步研究 被引量:10

Multi-b-value diffusion weighted imaging MRI in evaluation of renal tumors:preliminary results
原文传递
导出
摘要 目的:探讨高磁场强度下多b值扩散加权成像结合双指数模型对肾肿瘤的诊断价值。方法对2012年6月至2013年2月24例肾肿瘤患者及13例健康志愿者行常规MRI及多b值(0、20、50、100、200、400、600、800、1000 s/mm2)扩散加权成像检查。利用基于体素内不相干运动(intravoxel incoherent motion,IVIM)理论的双指数模型计算单纯扩散系数(slow ADC,Dslow)、假性扩散系数(fast ADC,Dfast )以及灌注分数( fraction of fast ADC,f),利用单指数模型计算表观扩散系数( standard ADC,ADCtot )。运用t检验及非参数Mann-Whitney U检验比较正常组肾实质、肿瘤同侧肾实质、透明细胞肾细胞癌组( clear cell renal cell carcinoma,CCRCC)以及非透明细胞癌组( non CCRCC, NCCRCC)各参数的差异,对CCRCC与NCCRCC之间具有统计学意义的参数进行受试者工作特征( receiver-operating characteristic,ROC)曲线分析,并计算诊断敏感性和特异性。结果 CCRCC组的ADCtot、Dfast、Dslow分别为(1.73±0.43)×10-3、(14.75±14.73)×10-3、(1.34±0.38)×10-3 mm2/s, NCCRCC组分别为(1.23±0.26)×10-3、(9.47±5.27)×10-3、(0.58±0.15)×10-3 mm2/s,ADCtot及Dslow组间比较差异有统计学意义(P=0.037,P=0.001)。正常肾实质的ADCtot及Dslow分别为(2.25±0.11)×10-3、(1.74±0.17)×10-3 mm2/s,与CCRCC组间比较差异有统计学意义( P=0.000,P=0.001)。各组间f值比较差异均无统计学意义( P>0.05)。各参数在肿瘤同侧肾实质与正常肾脏组之间差异均无统计学意义(P>0.05)。 Dslow鉴别CCRCC与NCCRCC组的敏感性(95%)及特异性(100%)最高,ROC曲线下面积为0.988。结论多b值弥散加权成像结合IVIM双指数模型有助于CCRCC与NCCRCC的鉴别诊断,其中Dslow的鉴别价值最大。 Objective To determine the significance of the quantitative parameters obtained from intravoxel incoherent motion ( IVIM) diffusion weighted imaging ( DWI) in differentiating renal tumors from normal renal tissues.Methods Twenty-four patients with surgical pathology-proven renal tumors and 13 volunteers with healthy kidneys were included.DWI was performed with 9 b-values (0, 20, 50, 100, 200, 400, 600, 800 and 1 000 s/mm2).The slow component of diffusion (Dslow), fast component of diffusion ( Dfast ) and fraction of fast ADC ( f) of the biexponential DWI were calculated for the clear cell renal cell carcinoma (CCRCC), the normal renal parenchyma and the non CCRCC ( NCCRCC) .The ADC was calculated for all b-values using linear regression yielding standard ADC ( ADCtot ) .The parameters were compared among the groups, and the receiver operating characteristic ( ROC ) analysis was performed. Results CCRCC showed higher ADCtot (1.73 ±0.43) ×10 -3 mm2/s, Dfast (14.75 ±14.73) ×10 -3 mm2/s, Dslow(1.34 ±0.38) ×10 -3 mm2/s than NCCRCC (ADCtot(1.23 ±0.26) ×10 -3 mm2/s, Dfast(9.47 ± 5.27) ×10 -3 mm2/s, Dslow(0.58 ±0.15) ×10 -3 mm2/s), and the differences of ADCtot(P=0.037) and Dslow(P=0.001) were significant.The normal renal parenchyma showed higher ADCtot (2.25 ±0.11) × 10 -3 mm2/s, Dslow ( 1.74 ±0.17 ) ×10 -3 mm2/s, f ( 35.00% ±9.37%) than CCRCC ( f, 31.13% ± 10.75%) and NCCRCC(f, 33.76%±24.02%), and the differences between the normal renal parenchyma and CCRCC of ADCtot ( P =0.000 ) and Dslow ( P =0.001 ) were significant.There were no differences between the normal renal parenchyma and the tumor ipsilateral renal parenchyma of all parameters.Dslow had higher accuracy ( sensitivity 95%, specificity 100%) in distinguishing CCRCC and NCCRCC, with area under the curve of 0.988.Conclusions Multi-b-value DWI derived quantitative parameters including ADCtot and Dslow may differ significantly between the renal tumor and normal renal parenchyma.Dslow is the best parameter in distinguishing CCRCC and NCCRCC.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2015年第6期419-422,共4页 Chinese Journal of Urology
基金 长海医院1255学科建设计划(CH125520800,CH125520303)
关键词 肾细胞 腺癌 透明细胞 磁共振成像 扩散 体素内不相干运动 Carcinoma,renal cell Adenocarcinoma,clear cell Diffusion magnetic resonance imaging Intravoxel incoherent motion
  • 相关文献

参考文献13

  • 1Stakhovskyi O, Yap SA, Leveridge M, et al. Small renal mass: what the urologist needs to know for treatment planning and assessment of treatment results[ J]. AJR Am J Roentgenol, 2011, 196 : 1267-1273.
  • 2李汉忠,孙颖浩,魏强,殷长军,王玉杰,毕建斌,王春喜,夏术阶,李黎明,曹晓明,梁朝朝,霍红旭,吴小侯,王剑松,王子明,顾晓箭,刘修恒,李逊,李亚健,张玉石.中国18家医院2008-2012年肾癌诊治现状分析[J].中华泌尿外科杂志,2014,35(6):406-409. 被引量:21
  • 3Millet I, Doyon FC, Hoa D, et al. Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? [ J]. A JR Am J Roentgenol, 2011, 197: 887-$96.
  • 4黄毅,阴雷,黄海,高轶,崔心刚,王军凯,叶剑青,徐丹枫.128例20~40岁肾细胞癌患者的临床病理特征及预后分析[J].中华泌尿外科杂志,2014,35(10):731-733. 被引量:3
  • 5许晓雯,王培军,马亮,邵志红,张敏.3.0T MRI扩散加权成像及灌注加权成像在肾脏良恶性肿瘤鉴别诊断中的价值[J].中华医学杂志,2015,95(3):200-204. 被引量:17
  • 6Sandrasegaran K, Sundaram CP, Ramaswamy R, et al. Usefulness of diffusion-weighted imaging in the evaluation of renal masses[J].AJR Am J Roentgenol, 2010, 194: 438-445.
  • 7Wang H, Cheng L, Zhang X, et al. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T [ J]. Radiology, 2010, 257 : 135-143.
  • 8Inci E, Hoeaoglu E, Aydin S, et al. Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification[ Jl. Eur J Radiol, 2012, 81 : 815-820.
  • 9Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions : application to diffusion and perfusion in neurologic disorders [ J ]. Radiology, 1986, 161 : 401-407.
  • 10Cercueil JP, Petit JM, Nougaret S, et al. Intravoxel incoherent motion diffusion-weighted imaging in the liver: comparison of mono-, bi- and tri-exponential modelling at 3. 0-T [J].Eur Radiol, 2015, 25: 1541-1550.

二级参考文献58

  • 1李涛,高元桂,高育,文载律,梁燕.肾癌假包膜征高场MRI表现特征、病理基础及意义[J].中华放射学杂志,1995,29(11):781-783. 被引量:19
  • 2张毅,郭顺林,雷军强,王文辉,白亮彩,赵茜静.磁共振扩散加权成像在肝癌介入治疗前后应用的初步研究[J].中国介入影像与治疗学,2006,3(3):182-185. 被引量:21
  • 3赵文华.恶性肿瘤流行趋势分析及预防的研究[J].天津科技,2006,33(3):38-39. 被引量:37
  • 4姜海,陈昭典,夏丹,朱选文,张志根,蔡松良.青年型肾癌56例报告[J].中华泌尿外科杂志,2007,28(1):9-11. 被引量:4
  • 5董柏君 张进 陈勇辉 等.上海仁济医院肾癌数据库资料分析[J].中华泌尿外科杂志,2008,29:222-225.
  • 6马建辉,何志嵩.肾细胞癌诊断治疗指南[M] //那彦群,孙光.中国泌尿外科疾病诊断治疗指南.2009版.北京:人民卫生出版社,2009:4-15.
  • 7顾方六,肾肿瘤[M]//吴阶平.泌尿外科学.上卷.济南:山东科学技术出版社,2004:895-896.
  • 8Delahunt B, Bethwaite PB, Nacey JN. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumors divided according to histological subtype. Pathology, 2007, 39 : 459-465.
  • 9Kono K, Inoue Y, Nakayama K, et al. The role of diffusion- weighted imaging in patients with brain tumors. AJNR, 2001,22 : 1081-1088.
  • 10Lam JS, Klatte T, Breda A. Staging of renal cell carcinoma:current concepts. Indian J Urol, 2009, 25: 446-454.

共引文献59

同被引文献142

  • 1张宁,龚侃,果宏峰,那熙,吴关,杨新宇,辛殿旗,那彦群.散发性肾透明细胞癌组织中VHL基因突变、血管内皮生长因子表达及其与微血管形成的关系[J].中华医学杂志,2004,84(19):1620-1624. 被引量:15
  • 2马建辉,周爱萍,孙燕.以VEGF为基础的肾癌分子靶向治疗的新进展[J].中华泌尿外科杂志,2006,27(12):797-799. 被引量:3
  • 3宫大鑫,李泽良,王侠,孙志熙,孔垂泽.双肾癌诊断和治疗策略[J].中华泌尿外科杂志,2007,28(9):585-587. 被引量:9
  • 4Le Bihan D, Breton E, Lallemand D, et aL MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders[J]. Radiology, 1986, 161(2): 401-407.
  • 5Zhang JL, Sigmund EE, Chandarana H, et al. Variability of renal apparent diffusion coefficients: limitations of the monoexponential model for diffusion Radiology, 2010, 254(3):783-792.
  • 6Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging[J]. Radiology, 1988, 168(2):497-505.
  • 7Le Bihan D, Turner R. The capillary network: a link between IVIM and classical perfusion[J]. Magn Reson Med, 1992, 27 (1):171-178.
  • 8Lemke A, Stiehjes B, Schad LR, et al. Toward an optimal distribution of b values for intravoxel incoherent motion imaging[J]. Magn Reson Imaging, 2011, 29(6):766-776.
  • 9Zhang JL, Sigmund EE, Rusinek H, et al. Optimization of b-value sampling for diffusion-weighted imaging of the kidney [J]. Magn Reson Med, 2012, 67(1):89-97.
  • 10Koh DM, Collins D J, Orton MR. Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges[J]. AJR Am J Roentgenol, 2011,196(6):1351-1361.

引证文献10

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部